Access to Medicine Programs in Developing Countries Increased by Pharmaceutical Companies
The issue of access to medicine is becoming increasingly important to pharmaceutical companies as evidenced by the increased development of access to medicine programs in the developing world.
Pharmaceutical giant Sanofi-Aventis, which has offices in the United States and France, launched Partnership for Prescription Assistance, a program designed to bring together pharmaceutical companies, community groups, doctors, and patient advocacy groups to ensure vulnerable populations have access to medicine.
In addition to region-specific access to medicine programs in developing countries, Johnson and Johnson has developed the Web site access2wellness.com to help people find ways to get the medicines they need. They also have a toll-free number for patients without access to a computer.
GlaxoSmithKline is currently researching and developing drugs and vaccines for three of the most deadly diseases that according to the World Health Organization receive little attention from most pharmaceutical companies: HIV/AIDS, malaria, and tuberculosis. According to the company Web site, “We look for innovative ways to increase access to medicines.”
Norvatis has also increased efforts to further the access to medicine programs it runs in other countries by reaching out to the World Health Organization (WHO) and other nongovernmental organizations.
About Pharmaceutical News 2.0:
Pharmaceutical News 2.0 presents information related to the issues facing the pharmaceutical industry. Pharmaceutical News 2.0 is edited by James Njoroge, a former journalist who comments on science and technology issues touching on the developing world.
- Contact Information
- James Njoroge
- Media Contact
- Pharmaceutical News 2.0
- Contact via E-mail
This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.
News Release Distribution and Press Release Distribution Services Provided by WebWire.